Pancreatic transcription factor reprogramming cocktail (PDX1, NGN3, MAFA) (PMN cocktail)

Transcription factor combinations driving somatic-to-beta-cell reprogramming are a set of regulatory proteins used to convert non-beta somatic cells into functional, insulin-secreting beta-like cells. The most prominent combination, often referred to as the PMN cocktail, consists of Pancreatic and duodenal homeobox 1 (PDX1), Neurogenin 3 (NGN3), and V-maf musculoaponeurotic fibrosarcoma oncogene homolog A (MAFA) (Zhou et al., 2008). These factors function by binding to specific genomic loci to activate the endocrine gene program and suppress the host cell's original identity, such as that of a pancreatic exocrine cell or a hepatocyte (Akinci et al., 2012). This approach is primarily investigated as a potential cure for Type 1 and Type 2 diabetes, where beta-cell mass is depleted or dysfunctional. Current research focuses on delivering these factors via viral vectors or inducing their expression using small-molecule drugs to avoid permanent genetic modification (Li et al., 2014). However, significant challenges remain, including the risk of incomplete reprogramming, potential tumorigenicity, and the need to protect newly formed cells from autoimmune destruction (Bang & Carpenter, 2017).

Other names

Somatic-to-beta-cell reprogramming factorsBeta-cell induction factorsPDX1-NGN3-MAFA cocktailPancreatic lineage-specifying factorsPMN factors

The mechanism involves the ectopic expression of lineage-specific transcription factors that cooperatively bind to the promoters and enhancers of beta-cell-specific genes, such as Insulin and Glut2, while simultaneously recruiting epigenetic modifiers to silence the original somatic cell's gene expression profile (Zhou et al., 2008; Akinci et al., 2012).